ArticleOncoTargets and therapy2013

Targeting 20-HETE producing enzymes in cancer - rationale, pharmacology, and clinical potential.

Anna Alexanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.